Wollenberg B - Search Results

1

Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer.

Weber P, Künstner A, Hess J, Unger K, Marschner S, Idel C, Ribbat-Idel J, Baumeister P, Gires O, Walz C, Rietzler S, Valeanu L, Herkommer T, Kreutzer L, Klymenko O, Drexler G, Kirchner T, Maihöfer C, Ganswindt U, Walch A, Sterr M, Lickert H, Canis M, Rades D, Perner S, Berriel Diaz M, Herzig S, Lauber K, Wollenberg B, Busch H, Belka C, Zitzelsberger H. Weber P, et al. Among authors: wollenberg b. Clin Cancer Res. 2022 Mar 1;28(5):1038-1052. doi: 10.1158/1078-0432.CCR-21-2244. Clin Cancer Res. 2022. PMID: 34965946

2

[Micrometastases in bone marrow of patients with cancers in the head and neck area].

Wollenberg B, Ollesch A, Maag K, Funke I, Wilmes E. Wollenberg B, et al. Laryngorhinootologie. 1994 Feb;73(2):88-93. doi: 10.1055/s-2007-997086. Laryngorhinootologie. 1994. PMID: 7512813 German.

3

CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.

Wollenberg B, Jan V, Schmit UM, Hofmann K, Stieber P, Fateh-Moghadam A. Wollenberg B, et al. Anticancer Res. 1996 Sep-Oct;16(5B):3117-24. Anticancer Res. 1996. PMID: 8920778

4

Anti-p53 antibodies in serum of smokers and head and neck cancer patients.

Wollenberg B, Jan NV, Pitzke P, Reiter W, Stieber P. Wollenberg B, et al. Anticancer Res. 1997 Jan-Feb;17(1A):413-8. Anticancer Res. 1997. PMID: 9066686

5

Serum levels of intercellular adhesion molecule-1 in squamous cell carcinoma of the head and neck.

Wollenberg B, Jan N, Sautier W, Hofmann K, Schmitt UM, Stieber P. Wollenberg B, et al. Tumour Biol. 1997;18(2):88-94. doi: 10.1159/000218019. Tumour Biol. 1997. PMID: 9222306

6

Changes in head and neck tumor hypoxic fraction during split-course radiochemotherapy.

Jund R, Feldmann HJ, Wollenberg B, Stadler P, Molls M. Jund R, et al. Among authors: wollenberg b. Ann Otol Rhinol Laryngol. 1999 Jan;108(1):73-8. doi: 10.1177/000348949910800111. Ann Otol Rhinol Laryngol. 1999. PMID: 9930544

7

Gene therapy--phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol.

Wollenberg B, Kastenbauer, Mundl H, Schaumberg J, Mayer A, Andratschke M, Lang S, Pauli C, Zeidler R, Ihrler S, Löhrs, Naujoks K, Rollston R. Wollenberg B, et al. Hum Gene Ther. 1999 Jan 1;10(1):141-7. doi: 10.1089/10430349950019273. Hum Gene Ther. 1999. PMID: 10022539

8

Targeting head and neck cancer by GM-CSF-mediated gene therapy in vitro.

Lang S, Zeidler R, Mayer A, Reiman V, Wollenberg B, Kastenbauer E. Lang S, et al. Among authors: wollenberg b. Anticancer Res. 1999 Nov-Dec;19(6B):5335-9. Anticancer Res. 1999. PMID: 10697558

9

Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1.

Zeidler R, Csanady M, Gires O, Lang S, Schmitt B, Wollenberg B. Zeidler R, et al. Among authors: wollenberg b. FASEB J. 2000 Apr;14(5):661-8. doi: 10.1096/fasebj.14.5.661. FASEB J. 2000. PMID: 10744623

10

Tumor necrosis factor alpha negatively regulates the expression of the carcinoma-associated antigen epithelial cell adhesion molecule.

Gires O, Kieu C, Fix P, Schmitt B, Münz M, Wollenberg B, Zeidler R. Gires O, et al. Among authors: wollenberg b. Cancer. 2001 Aug 1;92(3):620-8. doi: 10.1002/1097-0142(20010801)92:3<620::aid-cncr1362>3.0.co;2-f. Cancer. 2001. PMID: 11505407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page